The current NHLBI PACT program is funded through June 30, 2021. Therefore, the PACT program will only accept applications for services that can be completed by this date.
Registration is now open for the 10 December 2019 PACT Web Seminar Guidance for Submission of an Initial Investigational New Drug (IND) Application. Click here to register. The Web Seminar eflyer can be found on the Education > PACT Web Seminars page.
The Web Seminar handout for Guidance for Submission of an Initial Investigational New Drug (IND) Application can be found on the Education > PACT Web Seminars page. The registration link can also be found on the PACT Web Seminars page.
Under the aegis of the NIH Regenerative Medicine Innovation Project (RMIP), NIH is establishing a Regenerative Medicine Innovation Catalyst (RMIC) to catalyze the efficient development of safe and...
The NHLBI-led Cure Sickle Cell Initiative engages PACT to accelerate the development of promising genetic therapies. Learn more at https://curingsicklecell.nhlbi.nih.gov.
Registration is now closed for the June 19, 2018 PACT Web Seminar, Development of GMP Cell Manufacturing of Cardiac Stem Cells. The web seminar handouts are now posted and can be found on the Education > PACT Web Seminars page.
The 30 January 2018 FDA CTLM summary and slides are now available and posted to Education > Conferences/Workshops.
Integrated Training in Development and Clinical Practice of Cell Based Therapies at the University of Minnesota. For more information go to Education > Conferences/Workshops.
The NHLBI-funded PACT program was recently renewed. Contracts were awarded to the following Cell Processing Facilities: Center for Cell and Gene Therapy, Baylor College of Medicine (Houston, TX) Center for Biomedicine and Genetics, City of Hope (Duarte, CA) Moffitt Cancer Center (Tampa, FL) Interdisciplinary Stem Cell Institute Cellular Manufacturing Program (ISCI-CMP), University of Miami, Miller School of Medicine (Miami, FL) University of Minnesota Molecular and Cellular Therapeutics ...
The BEST Collaborative is seeking participations from cell processing laboratories Managers/Directors in a brief survey by July 1, 2017. This short survey is focused on novel cell therapy manufacturing and can be accessed by clicking here. The informative survey collects manufacturing data for similar products across institutions worldwide. In addition to providing information on various processing practices, the survey could facilitate collaboration across the globe. Survey results will be...